Literature DB >> 8472937

Neuro-ophthalmology and psychiatry.

N J Newman1.   

Abstract

Neuro-ophthalmology and psychiatry interact over several issues. The neuro-ophthalmologist can confirm the suspicion of nonorganic visual dysfunction by demonstrating the functional integrity of the visual system and the nonphysiologic nature of the visual complaints. He or she may recognize evidence of organic dysfunction in the patient with a presumed psychiatric diagnosis. In some cases, the pathology may be related to the use of certain psychiatric medications. Specialized examination techniques within the realm of neuro-ophthalmology may provide subtle information about the functional integrity of the central nervous system in patients with psychiatric disease. Clinical and investigational collaboration between the neuro-ophthalmologist and the psychiatrist will provide the most appropriate patient management and may further our understanding of the biological basis of psychiatry.

Entities:  

Mesh:

Year:  1993        PMID: 8472937     DOI: 10.1016/0163-8343(93)90106-x

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  4 in total

Review 1.  Non-organic visual loss.

Authors:  S Beatty
Journal:  Postgrad Med J       Date:  1999-04       Impact factor: 2.401

2.  Functional visual loss.

Authors:  Beau B Bruce; Nancy J Newman
Journal:  Neurol Clin       Date:  2010-08       Impact factor: 3.806

Review 3.  Functional vision disorders in adults: a paradigm and nomenclature shift for ophthalmology.

Authors:  Subahari Raviskanthan; Sydney Wendt; Peter M Ugoh; Peter W Mortensen; Heather E Moss; Andrew G Lee
Journal:  Surv Ophthalmol       Date:  2021-03-15       Impact factor: 6.197

4.  A Framework for Automating Psychiatric Distress Screening in Ophthalmology Clinics Using an EHR-Derived AI Algorithm.

Authors:  Samuel I Berchuck; Alessandro A Jammal; David Page; Tamara J Somers; Felipe A Medeiros
Journal:  Transl Vis Sci Technol       Date:  2022-10-03       Impact factor: 3.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.